Xtant Medical Holdings (XTNT) Misses Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Xtant Medical (XTNT) PT Raised to $3 at BTIG
May 16, 2024 5:30 AM EDTBTIG analyst Ryan Zimmerman raised the price target on Xtant Medical (NYSE: XTNT) to $3.00 (from $2.00) while maintaining a Buy rating.
The analyst comments "We maintain our Buy and raise our PT to $3 (from $2) following encouraging 1Q24 results. XTNT reported rev. of $27.9M (55.4% Y/Y) and LPS of ($0.03) ahead/below with BTIG/Consensus... More
